drugset / Trial / NCT01287182

Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis

NCT01287182

Phase 3 Completed 100 enrolled Omicron Pharmaceuticals
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a trial of Ateronon in Patients with Coronary Disease to Evaluate its Effectiveness in Assessing the Risk Factors of Atherosclerosis.

Timeline

Start
2011-05
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lycopene Other / unclassified

Indications